Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

Autor:	Slade, David1 (AUTHOR), Ray, Riju1 (AUTHOR), Moretz, Chad2 (AUTHOR), Germain, Guillaume3 (AUTHOR), Laliberté, François3 (AUTHOR), Shen, Qin4 (AUTHOR), Duh, Mei Sheng5 (AUTHOR), MacKnight, Sean D.3 (AUTHOR), Hahn, Beth2 (AUTHOR) Beth.a.hahn@gsk.com
Zdroj:	Pulmonary Therapy. Jun2021, Vol. 7 Issue 1, p203-219. 17p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu